Sheridan Adams

Sheridan Adams, LLC is a specialized investor relations and financial consulting firm based in Denver, Colorado, that provides strategic advisory services to the life sciences and biotechnology sectors. The firm focuses on supporting companies with capital raising activities, institutional investor outreach, and corporate communications to enhance market visibility and liquidity. Notably, in early 2026, the firm was engaged by Telo Genomics to lead its investor relations efforts as the company advanced its telomere-based diagnostic platform toward clinical milestones and regulatory submissions. Led by Scott Kozak, Sheridan Adams leverages deep industry connections to secure sell-side analyst coverage and facilitate participation in major healthcare investor conferences.